Purpose of Technology

Minimally invasive coronary artery bypass grafting (MI-CABG) techniques utilize less invasive cardiac surgical techniques than conventional CABG surgery in patients requiring surgical coronary revascularization for coronary artery disease (CAD). The goal of MI-CABG procedures is to achieve coronary revascularization without cardiopulmonary bypass (CPB) using limited access incisions in order to limit morbidity from CPB and reduce the surgical trauma and wound complications associated with median sternotomy.

Questions addressed in this report include:

• Are MIDCAB and MICS CABG effective in decreasing the need for repeat revascularization, reducing major adverse cardiac events, and preventing recurrence of angina?
• How do results of MIDCAB and MICS CABG compare with those of other surgical revascularization procedures (i.e., conventional CABG, off-pump coronary artery bypass [OPCAB]) and PCI?
• Are MIDCAB and MICS CABG safe?
• Have definitive patient selection criteria been established for MIDCAB and MICS CABG for treatment of symptomatic CAD?

These questions provide a framework for review and synthesis of the best available evidence, which is presented in this report, along with the Hayes Ratings for the technology. This report also provides background information about the condition being treated, a description of the technology, and the context for development of the technology. Other key elements addressed in the report include the regulatory status; applicable Medicare and commercial payer coverage policies; relevant ICD-9 and ICD-10 diagnosis codes; cost and cost effectiveness; credentialing; hospital length of stay; need for large case management; and ongoing and future clinical trials of the technology.

Posted in Directory Reports
This entry was posted on Thursday, December 29th, 2011 at 8:00 am.